A Follow-up Evaluation for Safety in Subjects Who Participated in a Phase 1 Study With BMS-986094 (INX-08189)

Safety, Reactogenicity, and Immunogenicity Study of a Lyophilized COVID-19 mRNA Vaccine

NCT05366296 ·Status: WITHDRAWN ·Phase: PHASE1

PTX-COVID19-B, an mRNA Humoral Vaccine, is Intended for Prevention of COVID-19 in a General Population. This Study is Designed to Evaluate Safety, Tolerability, and Immunogenicity of PTX-COVID19-B Vaccine in Healthy Seronegative Adults Aged 18-64

NCT04765436 ·Status: COMPLETED ·Phase: PHASE1

A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults

NCT05923424 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2/COVID-19) Neutralizing Antibody in Healthy Participants

NCT04532294 ·Status: COMPLETED ·Phase: PHASE1

A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination

NCT07330440 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1

A Phase 1 Study to Evaluate the Safety of MEDI7814 in Adult Volunteers

NCT01544361 ·Status: COMPLETED ·Phase: PHASE1

Study Evaluating Single Doses of ILV-095 in Healthy Subjects

NCT00822835 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety, Tolerability, and Immunogenicity of V350A and V350B in Healthy Participants (V350-001).

NCT06655324 ·Status: RECRUITING ·Phase: PHASE1

Placebo Controlled Evaluation of the Cell Mediated Immune Response of Cirrhotic Subjects to Zostavax™

NCT02958345 ·Status: COMPLETED ·Phase: PHASE4

A Multiple Dose Safety Study of PEG-IFN in Healthy Volunteers

NCT02125578 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Safety and Ability of the Vaccine to Induce Antibodies Against the Respiratory Syncytial Virus in Healthy Adults

NCT02298179 ·Status: COMPLETED ·Phase: PHASE1

Safety, Reactogenicity, and Immunogenicity of mRNA-1653 in Healthy Adults

NCT03392389 ·Status: COMPLETED ·Phase: PHASE1

The Safety and Immunogenicity of SCTV01C in Healthy Population Aged ≥18 Years Previously Vaccinated With Inactivated COVID-19 Vaccine.

NCT05043285 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

Safety, Tolerability, Pharmacokinetics of hzVSf-v13 in Healthy Adults (Intravenous and Subcutaneous Administration)

NCT04817202 ·Status: COMPLETED ·Phase: PHASE1

A Phase 2 Study to Describe the Safety and Immunogenicity of Respiratory Syncytial Virus Vaccine IN006 in Healthy Participants Aged 60 Years and Older

NCT07128121 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

A Phase 3 Study to Evaluate the Safety, Tolerability, and Immunogenicity of Multiple Production Lots and Dose Levels of BNT162b2 RNA-Based COVID-19 Vaccines Against COVID-19 in Healthy Participants

NCT04713553 ·Status: COMPLETED ·Phase: PHASE3

A Single Dose Escalation Study to Investigate the Safety, Tolerability and Pharmacokinetics of Intramuscular and Subcutaneous Long Acting GSK1265744 in Healthy Subjects

NCT01756131 ·Status: COMPLETED ·Phase: PHASE1

Study of GST-HG171/Ritonavir Compared With Placebo in Patients With Mild to Moderate COVID-19

NCT05656443 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Safety and Efficacy Study of GS-5806 in Healthy Volunteers Infected With Respiratory Syncytial Virus (RSV)

NCT01756482 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetic Characteristics of hzVSF-v13 in Healthy Male Volunteers

NCT03653208 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

NCT04860297 ·Status: COMPLETED ·Phase: PHASE3

A Study of Lebrikizumab in Healthy Japanese and Caucasian Volunteers

NCT01423318 ·Status: COMPLETED ·Phase: PHASE1

A Study to Learn About New COVD-19 RNA Vaccine Candidates for New Variants in Healthy Individuals

NCT05997290 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

NCT04927065 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates Against COVID-19 in Healthy Individuals

NCT04368728 ·Status: COMPLETED ·Phase: PHASE2/PHASE3